lexi
IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 229 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH ARTICLE

Cognitive enhancing effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on learning and memory

Nade V S, Kawale L A, Valte K D, Shendye N V

Year : 2015| Volume: 47| Issue : 3 | Page no: 263-269

   This article has been cited by
 
1 A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View
Hamid Soltani Zangbar, Ali Gorji, Tahereh Ghadiri
Molecular Neurobiology. 2021; 58(2): 536
[Pubmed]  [Google Scholar] [DOI]
2 Development and optimization of chitosan coated nanoemulgel of telmisartan for intranasal delivery: A comparative study
Ling Yuan Chin, Joyce Yi Pei Tan, Hira Choudhury, Manisha Pandey, Sreenivas Patro Sisinthy, Bapi Gorain
Journal of Drug Delivery Science and Technology. 2021; 62: 102341
[Pubmed]  [Google Scholar] [DOI]
3 Protective effects of perindopril against indomethacin-induced gastric mucosal damage through modulation of DDAH-1/ADMA and ACE-2/ANG-(1-7) signaling pathways
Yasmin T. Mohamed, Ibrahim A. Naguib, Ali A. Abo-Saif, Wafaa R. Mohamed
Drug and Chemical Toxicology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Beneficial effects of angiotensin converting enzyme inhibition on scopolamine-induced learning and memory impairment in rats, the roles of brain-derived neurotrophic factor, nitric oxide and neuroinflammation
Farimah Beheshti, Hamid Reza Akbari, Yousef Baghcheghi, Fatemeh Mansouritorghabeh, Sakineh Sadat Mortazavi Sani, Mahmoud Hosseini
Clinical and Experimental Hypertension. 2021; 43(6): 505
[Pubmed]  [Google Scholar] [DOI]
5 Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis
Adonis Sfera, Carolina Osorio, Carlos M. Zapata Martín del Campo, Shaniah Pereida, Steve Maurer, Jose Campo Maldonado, Zisis Kozlakidis
Frontiers in Cellular Neuroscience. 2021; 15
[Pubmed]  [Google Scholar] [DOI]
6 Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21
Liina Laukkanen, Cassiano R. A. F. Diniz, Sebastien Foulquier, Jos Prickaerts, Eero Castrén, Plinio C. Casarotto
Pharmaceuticals. 2021; 14(8): 773
[Pubmed]  [Google Scholar] [DOI]
7 Perindopril ameliorates experimental Alzheimer’s disease progression: role of amyloid ß degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling
Basim A. S. Messiha, Mohammed R. A. Ali, Mahmoud M. Khattab, Amira M. Abo-Youssef
Inflammopharmacology. 2020; 28(5): 1343
[Pubmed]  [Google Scholar] [DOI]
8 The Brain AT2R—a Potential Target for Therapy in Alzheimer’s Disease and Vascular Cognitive Impairment: a Comprehensive Review of Clinical and Experimental Therapeutics
Heba A. Ahmed, Tauheed Ishrat
Molecular Neurobiology. 2020; 57(8): 3458
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow